Preventive effect of isostrictiniin from Nymphaea candida on carbon tetrachloride-induced hepatic fibrosis in mice

被引:5
作者
Dong, Hui Juan [1 ]
Guo, Yuxuan [2 ]
Liu, Tao [1 ]
Zhao, Jun [3 ]
机构
[1] Xinjiang Med Univ, Coll Publ Hlth, Urumqi, Peoples R China
[2] Xinjiang Univ, Coll Life Sci & Technol, Urumqi, Peoples R China
[3] Inst Mat Med Xinjiang, Key Lab Uighur Med, Urumqi, Peoples R China
基金
中国国家自然科学基金;
关键词
Nymphaea candida; isostrictiniin; hepatic fibrosis; CCl4; NF-kappa B; EXPERIMENTAL-MODELS; LIVER FIBROSIS; EXTRACT; INJURY;
D O I
10.1080/14786419.2022.2065673
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
This study aimed to investigate the preventive effect of isostrictiniin (ISO) from Nymphaea candida against CCl4-induced hepatic fibrosis (HF) in mice. HF in mice was induced by intraperitoneally injecting 10% CCl4 olive oil solution twice a week. After intragastric administration for 8 weeks. ISO (25, 50, or 100mg/kg) could significantly reduce the serum AST, ALT, ALP, HA, LN, PC-III, C-IV, IL-1 beta, and TNF-alpha levels in HF mice, and the collagen fiber deposition in ISO group was significantly less than that in the model group. Compared with control group, the protein expression of IKK alpha, NF-kappa B p65, p-NF-kappa KB p65, p-I kappa B alpha in model group were increased as well as the relative content of IKK alpha, NF-kappa B p65, and I kappa B alpha mRNA. ISO could reverse the expression of these relative proteins and mRNA in HF mice. Our findings confirm that ISO has anti-HF activity, and its mechanism is related to the regulation of NF-kappa B pathway. [GRAPHICS]
引用
收藏
页码:628 / 632
页数:5
相关论文
共 18 条
  • [1] Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators
    Algandaby, Mardi M.
    El-Halawany, Ali M.
    Abdallah, Hossam M.
    Alahdal, Abdulrahman M.
    Nagy, Ayman A.
    Ashour, Osama M.
    Abdel-Naim, Ashraf B.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (04) : 419 - 428
  • [2] Regression of Liver Fibrosis
    Campana, Lara
    Iredale, John P.
    [J]. SEMINARS IN LIVER DISEASE, 2017, 37 (01) : 1 - 10
  • [3] Liver function test and pregnancy
    Jamjute, Pradumna
    Ahmad, Amir
    Ghosh, Tarun
    Banfield, Philip
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2009, 22 (03) : 274 - 283
  • [4] Liu YM., 1999, PHARMACOGRAPHY UIG 1, V119
  • [5] NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma
    Luedde, Tom
    Schwabe, Robert F.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (02) : 108 - 118
  • [6] Maierdan T., 2018, J XINJIANG MED U, V41, P321
  • [7] Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection
    Marques, Thamirys Guimaraes
    Chaib, Eleazar
    da Fonseca, Juliana Hamati
    Rodrigues Lourenco, Ana Cecilia
    Silva, Felipe Duarte
    Fontenelle Ribeiro, Marcelo Augusto, Jr.
    Ferreira Galvao, Flavio Henrique
    Carneiro D'Albuquerque, Luiz Augusto
    [J]. ACTA CIRURGICA BRASILEIRA, 2012, 27 (08) : 589 - 594
  • [8] Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
    Parola, Maurizio
    Pinzani, Massimo
    [J]. MOLECULAR ASPECTS OF MEDICINE, 2019, 65 : 37 - 55
  • [9] Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways
    Seki, Ekihiro
    Schwabe, Robert F.
    [J]. HEPATOLOGY, 2015, 61 (03) : 1066 - 1079
  • [10] Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways
    Wang, Rong
    Song, Fuxing
    Li, Shengnan
    Wu, Bin
    Gu, Yanqiu
    Yuan, Yongfang
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1889 - 1900